Irawan Fajar Kusuma
Department of Internal Medicine, Faculty of Medicine Jember University /dr. Soebandi General Hospital Jember

Adelia Handoko
Department of Physiology, Faculty of Medicine Jember University

DOI: https://doi.org/10.19184/ams.v8i1.25235

Abstract

Ascariasis is still one of the most common soil transmitted helminths (STH) infections found in all ages, including adults. This is due to the fact that the parasite is able to manipulate the host's immune response by increasing the IgG4 levels. IgG4 detection by ELISA method is an examination used to determine specific antibodies to the A. lumbricoides antigen in blood samples. This examination is specifically used to detect ascariasis where the reagent used is A. lumbricoides IgG4 ELISA Kit.This study is aimed to determine the prevalence of ascariasis based on IgG4 levels using the ELISA method in adults at Pasie Nan Tigo Village, Padang City. This study is a descriptive study with a cross-sectional design that took place from July 2020 - May 2021 using a multistage random sampling technique where a total of 78 adult respondents in Pasie Nan Tigo Village. Blood samples were taken in order to check their IgG4 levels, using the ELISA at Prodia Laboratory. Data analysis was performed univariately with the purpose of finding the frequency distribution. The results of this study show that from the total of 78 respondents, the majority of age group found is 46-55 years old, namely 28 respondents, the majority of gender is female, namely 65 respondents, 57 respondents were positive for IgG4 where the most sufferers are 17-25 years old (88.9 %) and male (76.9%). The conclusion of this study is most of the respondents were in the age group of 46-55 years and women, there were more than half of the total respondents who detected ascariasis with the most sufferers being the age group of 17-25 years and men.

Keyword: Ascaris lumbricoides, STH, IgG4.

REFERENCE

1. Golabi, P., Fazel, S., Otgonsuren, M., Sayiner, M., Locklear, C. T., & Younossi, Z. M. (2017). Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities. Medicine (United States), 96(9). https://doi.org/10.1097/MD.0000000000005904

2. Heinrich, S., Sprinzl, M., Schmidtmann, I., Heil, E., Koch, S., Czauderna, C., Heinrich, B., Philippe P Diggs, L., Wörns, M. A., Kloeckner, R., Galle, P. R., Marquardt, J. U., & Weinmann, A. (2020). Validation of prognostic accuracy of MESH, HKLC, and BCLC classifications in a large German cohort of hepatocellular carcinoma patients. United European Gastroenterology Journal, 8(4), 444–452. https://doi.org/10.1177/205064062090452 4

3. Kementerian Kesehatan Republik Indonesia. (2019). Hari Kanker Sedunia 2019. https://www.kemkes.go.id/article/view/19020100003/hari-kanker-sedunia-2019.html [Diakses pada 21 Mei 2020]

4. Kim, K. M., Sinn, D. H., Jung, S. H., Gwak, G. Y., Paik, Y. H., Choi, M. S., Lee, J. H., Koh, K. C., & Paik, S. W. (2016). The recommended treatment algorithms of the BCLC and HKLC staging systems: does following these always improve survival rates for HCC patients? Liver International, 36(10), 1490–1497. https://doi.org/10.1111/liv.13107

5. Kinoshita, A., Onoda, H., Fushiya, N., Koike, K., Nishino, H., & Tajiri, H. (2015). Staging systems for hepatocellular carcinoma: Current status and future perspectives. World Journal of Hepatology, 7(3), 406–424. https://doi.org/10.4254/wjh.v7.i3.406

6. Perhimpunan Peneliti Hati Indonesia (PPHI). 2017. Konsensus Nasional Penatalaksanaan Karsinoma Sel Hati. Jakarta: PPHI